Skip to content

Drug interactions

Safinamide + Trifluoperazine

Severity: Major

Safinamide and Trifluoperazine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Trifluoperazine blocks dopamine D2 receptors and can oppose the dopaminergic benefit of safinamide in Parkinson disease. Motor symptoms may worsen, and extrapyramidal effects from the antipsychotic may be added.

What this interaction means in plain words

Safinamide and Trifluoperazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Pharmacodynamic antagonism between a dopamine D2 antagonist and a dopaminergic antiparkinson agent.

What to do

Avoid trifluoperazine in patients with Parkinson disease where possible; if an antipsychotic is required, choose a low-D2-affinity agent such as quetiapine or clozapine. Monitor motor function closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Safinamide and Trifluoperazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Safinamide with Trifluoperazine?

MediHelp rates the interaction as major. Safinamide and Trifluoperazine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Trifluoperazine blocks dopamine D2 receptors and can oppose the dopaminergic benefit of safinamide in Parkinson disease. Motor symptoms may worsen, and extrapyramidal effects from the antipsychotic may be added.

How serious is the interaction between Safinamide and Trifluoperazine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid trifluoperazine in patients with Parkinson disease where possible; if an antipsychotic is required, choose a low-D2-affinity agent such as quetiapine or clozapine. Monitor motor function closely.

What other medicines interact with Safinamide?

MediHelp also lists interactions of Safinamide with, for example, Amitriptyline, Amoxapine, Amphetamine polistirex. The full list is on the Safinamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in